Researchers who can monitor a cancer tumour as it changes and help direct radiation right into its centre believe they may be able to increase the efficiency of cancer treatment by at least a sixth.
The use of chemotherapy, which involves tumour-fighting drugs, in combination with radiation treatment, is a mainstay of cancer medicine. It is sophisticated, expensive and risky, involving some of the most technologically advanced equipment.
New techniques enable researchers to redistribute the radiation dose. This typically involves delivering a similar dose of radiation, but focusing the dose more exactly at the epicentre of the tumour, so that the force of the treatment is delivered where it is most required.
However, identification of the epicentre of the tumour is not a fixed art. Tumours subtly evolve and move as they grow, and as they respond to treatment.
The EU-funded ARTFORCE consortium – a group of clinical centres and companies in Europe – monitors both the geometry of the affected area, and the delivered dose, using state-of-the-art imaging. This means that there is a constant loop-back of information enabling this so-called ‘adaptive’ therapy to continue to change in response to the changes in the tumour.
‘Biological optimisation of radiation dose distribution will result in a higher cure rate without increasing toxicity,’ according to Olga Hamming-Vrieze, an oncologist working on the ARTFORCE project at the Netherlands Cancer Institute.
By redistributing an existing dose, there is no greater toxic content, which is critical since the aim of successful radiotherapy is to beam no more radiation than necessary at the patient.
The individualised approaches to these sophisticated treatments being used by ARTFORCE should also result in savings. Targeted treatment means cutting down on wasteful and expensive remedies.
Response to drugs
In addition to the advanced radiotherapy methods, the researchers conduct early biometric and other tests on the tumours to see how well they respond to leading cancer chemotherapy treatments Cisplatin and Cetuximab, before deciding which one to use.
The problem of how to dose the radiotherapy towards the tumour and secondly what type of chemotherapy to use are crucial. Patients, and their tumours, are never alike, and these treatments can have substantial side-effects.
Before radiological treatment, the location of the tumour is precisely established thanks to different imaging techniques. © RaySearch Laboratories
The individualised regimen that ARTFORCE allows makes the treatment work better, and improves the patients' quality of life, since treatments that would be less efficient are withheld. Early indications suggest the techniques developed by ARTFORCE could increase efficiency of treatment by at least 15 %.
The way that ARTFORCE is structured also sets an example. In a field requiring highly advanced equipment, only by cooperation can EU institutes pool the type of resources necessary to create definitive results.
Under ARTFORCE, there is cooperation between the European Society for Radiotherapy and Oncology, and a range of specialist units across the continent such as Manchester’s The Christie Hospital, the Netherlands Cancer Institute, Sweden’s Karolinska Institutet, France’s Institut Gustave Roussy, and Spain’s Hospital Vall d'Hebron. In addition, running in parallel is the involvement of RaySearch – a company developing advanced applications for radiation therapy including tools for dose tracking and adaptive therapy.
ARTFORCE, which began in 2012, is currently approaching the end of clinical trials, which are attempting to prove the benefits of this technique.
Some materials are special not for what they contain, but for what they don’t contain. Such is the case with metal-organic frameworks (MOFs) – ultra-porous structures that are being developed for a variety of future applications from fire-proofing to drug-delivery.
Tiny pieces of plastic, now ubiquitous in the marine environment, have long been a cause of concern for their ability to absorb toxic substances and potentially penetrate the food chain. Now scientists are beginning to understand the level of threat posed to life, by gauging the extent of marine accumulation and tracking the movement of these contaminants.
Artificial intelligence (AI) and cyber security should be priorities in future EU industrial research policy in order to reinvigorate industry and recover jobs that have been lost abroad, according to Professor Jürgen Rüttgers, a former research minister in Germany.
The world’s largest radio telescope, known as the Square Kilometre Array (SKA) and situated over two continents, will be able to detect the first stars and galaxies emerging from the ‘murk’ at the beginning of the universe and much more besides, according to Professor Phil Diamond, Director General of SKA. He spoke to Horizon at the opening of the Shared Sky art exhibition in Brussels, Belgium on 16 April, where indigenous artists from SKA host nations South Africa and Australia use traditional painting and folk art to explore the themes of astronomy, spirituality and a borderless sky.
Are metal organic frameworks the hole-y grail of nanomaterials?
Tiny plastic particles could impact human health.
A new report on how to reinvigorate Europe's industrial sector recommends prioritising AI and cyber security research.